Avalo Therapeutics Appoints Jennifer Riley As Chief Strategy Officer
01/02/25, 12:23 PM
Location
rockvilleIndustry
therapeutics
biotechnology
health care
Position
chief strategy officer
Avalo Therapeutics, Inc. appointed Jennifer Riley as Chief Strategy Officer, effective January 1, 2025. In this role, Ms Riley will oversee corporate strategy and commercial and product pipeline planning to drive growth and innovation across the organization.
Company Info
Location
rockville, maryland, united states
Additional Info
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.